Rheumatoid Arthritis Clinical Trial
What is Rheumatoid Arthritis?
Rheumatoid Arthritis is a chronic, immune-mediated disease causing pain, stiffness, swelling and loss of joint function. Joint deformity and bone erosion can result from the associated swelling. RA can reduce patients’ ability to perform everyday tasks.
About the Study
A randomized, double-blind, parallel-group, Phase 2,multicenter study designed to assess the safety and efficacy of ABBV-105, upadacitinib, and ABBV-599 (ABBV-105 plus upadacitinib) in subjects with active RA who have had inadequate response to bDMARD therapy and are on stable background csDMARD treatment.
Compensation for Time and Travel
Study participants who satisfy applicable requirements – All study related visits, care, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided. Please contact us for more information as it varies by each study.
Eligibility to Participate
If you are 18 years of age or older and diagnosed with Rheumatoid Arthritis
This clinical research study will evaluate the effectiveness of an investigational drug for the treatment of Rheumatoid Arthritis
This information is not inclusive of the required eligibility criteria.
Please Call or Text our office at 407-574-5650 to learn more and book a no cost assessment with our Research Physicians.